Aversion conditioning treatment of alcoholism

Cardiac pacemakers and implantable defibrillators in terminal care

The use of cardiac pacemakers and arrhythmia control devices is increasingly common. The presence of a previously placed pacemaker or implantable cardioverter-defibrillator (ICD) in a terminally ill patient may result in medical and ethical issues for the patient, family, and healthcare provider. Two cases are presented to illustrate the complex issues that may arise in the terminally ill with a pacemaker or an ICD. Based on these cases and a review of published data, it is likely that the disabling of a previously placed pacemaker will neither hasten nor prolong the natural history of the underlying illness in most instances. There are uncommon but potentially severe adverse effects of disabling the pacemaker; therefore, pacemakers should generally be left intact in terminally ill patients. It is more difficult to generalize as to whether deactivation of an ICD is appropriate; in this case death may be hastened and the decision concerning an ICD will depend on the specific clinical scenario. Patient and family education regarding palliative care treatment goals and the function of pacemakers and other implanted arrhythmia control devices can help to alleviate anxiety surrounding the impact of this technology at the end of life.

Chemical aversion treatment of alcohol dependence

Developments in the application of chemical aversion therapy to the treatment of alcohol dependence are discussed. Historical factors leading to the early use of chemical aversion therapies are delineated and the theoretical underpinnings of chemical aversion interventions are evaluated. Ethical and procedural considerations are addressed and an assessment of the efficacy of the therapy is attempted. Future research activities that would lead to refinement of chemical aversion therapy protocols are highlighted. The effectiveness of chemical aversion treatment of alcohol dependence is discussed vis-a-vis production of condition alcohol-aversion and treatment outcome.

Behavioral therapies for substance abuse

The authors review more than two decades of research in the use of behavioral interventions for the treatment of drug and alcohol abuse. This survey covers major areas of research activity, including the use of aversive stimuli (chemical, electrical, and covert), skills training, contingency management, extinction/desensitization, and combined behavioral treatments. The reviewers conclude that while many of these treatment interventions hold promise, few have been fully explored with the use of properly controlled group studies. Suggestions are offered which may facilitate research and aid in the evaluation of behavioral interventions for substance abuse.

Aversive therapies for substance abuse: do they work?

More than two decades of research in the use of aversive behavioral interventions for the treatment of drug and alcohol abuse is reviewed. This survey covers only the areas of conditioned aversive states (using chemical or electrical stimuli) and extinction/desensitization. While many of these treatment interventions hold promise, none has been fully explored with properly controlled group studies. Suggestions are offered which may aid in the evaluation of behavioral interventions for substance abuse and increase the clinical impact of this work.